<PAGE>
FORM 10-Q/A
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
QUARTERLY REPORT UNDER SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarter ended June 30, 1996 Commission File Number 0-16594
MEDICAL TECHNOLOGY SYSTEMS, INC.
------------------------------------------------------------------
(Exact name of Registrant as specified in its charter)
DELAWARE 59-2740462
- ------------------------------- ---------------------------
(State or other jurisdiction of (I.R.S. Employer ID Number)
incorporation or organization)
12920 Automobile Boulevard, Clearwater, Florida 34622
-----------------------------------------------------
(address of principal executive offices)
Registrant's telephone number, including area code: (813) 576-6311
Indicate by check mark whether the Registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (for shorter period that the Registrant
was required to file such reports) and (2) has been subject to such filing
requirements for the past 90 days. YES X NO
----- -----
Indicate the number of shares outstanding of each of the issuer's
classes of common stock, as of the latest practicable date.
Class Outstanding at June 30, 1996
----- ----------------------------
Common Stock, $.01 par value 5,445,335
Preferred Stock, $.0001 par value 6,500,000
<PAGE>
MEDICAL TECHNOLOGY SYSTEMS, INC. AND SUBSIDIARIES
PART II - OTHER INFORMATION
ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K
No exhibits are included herein. The Company did not file any reports on
Form 8-K during the three months ended June 30, 1996.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this Quarterly Report to be signed on its behalf
by the undersigned, thereunto duly authorized, in the County of Pinellas,
State of Florida, on the 27th day of August 1996.
MEDICAL TECHNOLOGY SYSTEMS, INC.
By: /s/ MICHAEL P. CONROY
-------------------------------------------
Michael P. Conroy
Vice President & Chief Financial Officer
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
UNAUDITED FINANCIAL STATEMENTS OF MEDICAL TECHNOLOGY SYSTEMS INC. FOR THE 3
MONTHS ENDED JUNE 30, 1996 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> MAR-31-1997
<PERIOD-START> APR-01-1996
<PERIOD-END> JUN-30-1996
<CASH> 1328
<SECURITIES> 0
<RECEIVABLES> 3676
<ALLOWANCES> 686
<INVENTORY> 2331
<CURRENT-ASSETS> 7728
<PP&E> 8169
<DEPRECIATION> 3514
<TOTAL-ASSETS> 14282
<CURRENT-LIABILITIES> 2108
<BONDS> 0
0
1
<COMMON> 55
<OTHER-SE> 8320
<TOTAL-LIABILITY-AND-EQUITY> 14282
<SALES> 4882
<TOTAL-REVENUES> 4882
<CGS> 2846
<TOTAL-COSTS> 4519
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 0
<INCOME-PRETAX> 363
<INCOME-TAX> 0
<INCOME-CONTINUING> 363
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 363
<EPS-PRIMARY> .07
<EPS-DILUTED> .07
</TABLE>
